Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305055 · ClinicalTrials.gov registry record · Phase 4
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain
A Phase 4 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT03305055: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.
NCT03305055 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03305055, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The Ketamine for Acute Pain in Burns study is a randomized, double-blind, parallel group trial (RCT) with active control (usual care) contrasting the efficacy and safety of "Ketamine Plus Opiate-based usual care" (O+K) with the safety and efficacy of the "Current Standard of Care". THe current standard of care is an opiate medication alone, Fentanyl (Usual Care-Opiate (UC-O), dose/timing as per Burn Center protocol).
Interventions
- DRUG ketamine
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-12-16 |
| Est. Completion | 2018-04-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305055
The ClinicalTrials.gov registry entry for NCT03305055 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ketamine is the first listed.
NCT03305055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03305055 about?
NCT03305055 is a clinical study titled "RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain". The Ketamine for Acute Pain in Burns study is a randomized, double-blind, parallel group trial (RCT) with active control (usual care) contrasting the efficacy and safety of "Ketamine Plus Opiate-based usual care" (O+K) with the safety and efficacy of the "Current Standard of Care". THe current stand...
What is the current status of trial NCT03305055?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2017-12-16. Estimated completion is 2018-04-21.
What interventions are being tested in trial NCT03305055?
The interventions under investigation include: ketamine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT03305055?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.